ACTIVITY OVERVIEW
The content of this FREE online archive was derived from a live, educational teleconference/webcast presented by the Crohn’s & Colitis Foundation of America on Wednesday, June 16, 2010.

MEDIUM: Online Archive
INTERNET RELEASE DATE: June 30, 2010
(Continuing education credit is no longer available for this activity.)

Estimated time to complete this activity: 1.5 hours

The online archive format enables you to:

• View presentation slides and listen to the audio simultaneously
• Download a transcript of the presentation
• Download a copy of the presentation slides

Patients and caregivers can participate by completing an evaluation form to help us plan for future educational activities. This activity will answer important questions about women with inflammatory bowel diseases (IBD).

SPEAKERS
  Sunanda V. Kane, MD, MSPH
  Associate Professor of Medicine
  Mayo Clinic College of Medicine
  Rochester, Minnesota

  Uma Mahadevan-Velayos, MD
  Associate Professor of Medicine
  University of California, San Francisco (UCSF)
  Director of Clinical Research
  UCSF Center for Colitis and Crohn's Disease
  San Francisco, California

TARGET AUDIENCE
This activity is designed to meet the educational needs of registered nurses and other healthcare professionals involved in the care of patients with inflammatory bowel diseases (IBD).

ACTIVITY PURPOSE
This activity is intended to assist healthcare professionals in understanding the management of IBD in women.

STATEMENT OF NEED
Inflammatory bowel diseases commonly affect women in their childbearing years. Healthcare professionals must recognize the importance of encouraging female patients to openly express their concerns regarding future pregnancy, clinical symptoms of menses and menopause, sexuality, and overall quality of life. For example, "voluntary" childlessness in women with IBD often arises from a mistaken belief that their disease places them at unduly high risk for adverse reproductive outcomes.1 The menstrual cycle may be disrupted due to various disease-related factors, and menopause may occur sooner than expected in women with IBD.2 Disease activity in IBD, as well as medical and surgical treatment modalities, can also profoundly affect a woman's body image and sexuality.3 Additionally, stress may influence the activity or course of IBD and need to be taken into consideration during routine counseling. Unfortunately, such gender-related issues are not routinely addressed. Therefore, healthcare professionals must provide care, education, and support that allow women to better cope with chronic disease and adjust to the challenges of IBD.

1 Mountfield R, et al. Inflamm Bowel Dis. 2009;15:720-725.
2 Okoro NI, et al. Expert Rev Gastroenterol Hepatol. 2009;3:145-154.
3 Reddy SI, et al. J Am Osteopath Assoc. 2001;101(12 Suppl Pt 2):S17-S23.

LEARNING OBJECTIVES
After completing this activity, the participant should be better able to:

• Explain the impact of inflammatory bowel disease (IBD) on fertility and pregnancy
• Describe the effects of the menstrual cycle on IBD symptoms
• Cite the effects of menopause on IBD symptoms
• Recognize how female sexuality is affected by IBD
• Distinguish lifestyle factors, including stress, that affect IBD disease course in women

NURSING CONTINUING EDUCATION
CREDIT DESIGNATION
This educational activity for 1.5 ANCC contact hours is provided by Postgraduate Institute for Medicine (PIM).

ACCREDITATION STATEMENTS
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

CALIFORNIA BOARD OF REGISTERED NURSING
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.8 contact hours.

Upon successfully completing the learning assessment and evaluation form online, your statement of credit will be made available immediately.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CNE credit for this activity. During the period June 30, 2010, through June 30, 2011, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CNE by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on "Find Post-Test/Evaluation by Course" and search by course ID 7344. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CNE activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studied utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CNE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CNE activity:

• Dr. Sunanda V. Kane has an affiliation with Kyorin Pharmaceuticals (Speakers Bureau); Shire, Elan (Research).
• Dr. Uma Mahadevan-Velayos has an affiliation with Centocor, Abbott, UCB, Elan, Biogen, Shire, and Takeda (Consultant); Abbott (Research).

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CNE activity:

Robert Michael Educational Institute LLC

• Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
• Laura Altobelli, MS, has no affiliations with commercial interests to disclose.

Postgraduate Institute for Medicine

• Jan Hixon, RN, BSN, MA, has no affiliations with commercial interests to disclose.
• Trace Hutchison, PharmD, has no affiliations with commercial interests to disclose.
• Julia Kimball, RN, BSN, has no affiliations with commercial interests to disclose.
• Samantha Mattiocci, PharmD, has no affiliations with commercial interests to disclose.
• Jan Schultz, RN, MSN, CCMEP, has no affiliations with commercial interests to disclose.
• Patricia Staples, MSN, NP-C, CCRN, has no affiliations with commercial interests to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Robert Michael Educational Institute LLC (RMEI), Crohn’s & Colitis Foundation of America (CCFA), and Shire do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Robert Michael Educational Institute LLC (RMEI), Crohn’s & Colitis Foundation of America, and Shire. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their professional development. The information presented in this activity is not meant to server as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

SUPPORT STATEMENT
This continuing education activity is co-sponsored by Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine, and is supported by an educational grant from Shire.

FEE INFORMATION
There is no fee for this educational activity.

QUESTIONS & TECHNICAL ASSISTANCE
For technical assistance, contact jungsen@rmcom.net.

SYSTEM REQUIREMENTS
Hardware/Software requirements include:
• Windows 95, 98se, ME, XP, NT 4.0, 2000   
  - Internet Explorer 4.0+
  - Netscape Navigator 6.2+
  - AOL 8
  - Mozilla Firefox 1.0+
• Macintosh 9.2, OS X 10.1+
  - Safari 1.1+
  - Netscape Navigator 6.2+
  - Internet Explorer 5.2+
  - Mozilla Firefox 1.0+
• Additional requirements
  - Macromedia Flash Player 7
  - Internal/external speakers
  - Broadband connection (DSL/cable) recommended

For more information about the Crohn’s & Colitis Foundation of America, visit www.ccfa.org.

Additional educational activities offered by Robert Michael Educational Institute LLC can be found at www.RMEI.com or by calling toll free to 866-770-RMEI.

RMEI Privacy Statement